Outcomes of Elective and Emergency Conversion in Minimally Invasive Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma: An International Multicenter Propensity Score-matched Study.


Journal

Annals of surgery
ISSN: 1528-1140
Titre abrégé: Ann Surg
Pays: United States
ID NLM: 0372354

Informations de publication

Date de publication:
01 12 2021
Historique:
pubmed: 19 12 2019
medline: 16 12 2021
entrez: 19 12 2019
Statut: ppublish

Résumé

The aim of this study was to investigate the impact of conversion during minimally invasive distal pancreatectomy (MIDP) for pancreatic ductal adenocarcinoma (PDAC) on outcome by a propensity-matched comparison with open distal pancreatectomy (ODP). MIDP is associated with faster recovery as compared with ODP. The high conversion rate (15%-25%) in patients with PDAC, however, is worrisome and may negatively influence outcome. A post hoc analysis of a retrospective cohort including distal pancreatectomies for PDAC from 34 centers in 11 countries. Patients requiring conversion were matched, using propensity scores, to ODP procedures (1:2 ratio). Indications for conversion were classified as elective conversions (eg, vascular involvement) or emergency conversions (eg, bleeding). Among 1212 distal pancreatectomies for PDAC, 345 patients underwent MIDP, with 68 (19.7%) conversions, mostly elective (n = 46, 67.6%). Vascular resection (other than splenic vessels) was required in 19.1% of the converted procedures. After matching (61 MIDP-converted vs 122 ODP), conversion did not affect R-status, recurrence of cancer, nor overall survival. However, emergency conversion was associated with increased overall morbidity (61.9% vs 31.1%, P= 0.007) and a trend to worse oncological outcome compared with ODP. Elective conversion was associated with comparable overall morbidity. Elective conversion in MIDP for PDAC was associated with comparable short-term and oncological outcomes in comparison with ODP. However, emergency conversions were associated with worse both short- and long-term outcomes, and should be prevented by careful patient selection, awareness of surgeons' learning curve, and consideration of early conversion when unexpected intraoperative findings are encountered.

Sections du résumé

OBJECTIVE
The aim of this study was to investigate the impact of conversion during minimally invasive distal pancreatectomy (MIDP) for pancreatic ductal adenocarcinoma (PDAC) on outcome by a propensity-matched comparison with open distal pancreatectomy (ODP).
BACKGROUND
MIDP is associated with faster recovery as compared with ODP. The high conversion rate (15%-25%) in patients with PDAC, however, is worrisome and may negatively influence outcome.
METHODS
A post hoc analysis of a retrospective cohort including distal pancreatectomies for PDAC from 34 centers in 11 countries. Patients requiring conversion were matched, using propensity scores, to ODP procedures (1:2 ratio). Indications for conversion were classified as elective conversions (eg, vascular involvement) or emergency conversions (eg, bleeding).
RESULTS
Among 1212 distal pancreatectomies for PDAC, 345 patients underwent MIDP, with 68 (19.7%) conversions, mostly elective (n = 46, 67.6%). Vascular resection (other than splenic vessels) was required in 19.1% of the converted procedures. After matching (61 MIDP-converted vs 122 ODP), conversion did not affect R-status, recurrence of cancer, nor overall survival. However, emergency conversion was associated with increased overall morbidity (61.9% vs 31.1%, P= 0.007) and a trend to worse oncological outcome compared with ODP. Elective conversion was associated with comparable overall morbidity.
CONCLUSIONS
Elective conversion in MIDP for PDAC was associated with comparable short-term and oncological outcomes in comparison with ODP. However, emergency conversions were associated with worse both short- and long-term outcomes, and should be prevented by careful patient selection, awareness of surgeons' learning curve, and consideration of early conversion when unexpected intraoperative findings are encountered.

Identifiants

pubmed: 31850984
pii: 00000658-202112000-00395
doi: 10.1097/SLA.0000000000003717
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1001-e1007

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest.

Références

De Rooij T, van Hilst J, van Santvoort H, et al. Minimally invasive versus open distal pancreatectomy (LEOPARD). Ann Surg 2019; 269:2–9.
Mehrabi A, Hafezi M, Arvin J, et al. A systematic review and meta-analysis of laparoscopic versus open distal pancreatectomy for benign and malignant lesions of the pancreas: it's time to randomize. Surgery 2015; 157:45–55.
Abu Hilal M, Hamdan M, Di Fabio F, et al. Laparoscopic versus open distal pancreatectomy: a clinical and cost-effectiveness study. Surg Endosc Other Interv Tech 2012; 26:1670–1674.
Jayaraman S, Gonen M, Brennan MF, et al. Laparoscopic distal pancreatectomy: evolution of a technique at a single institution. J Am Coll Surg 2010; 211:503–509.
Nassour I, Wang SC, Porembka MR, et al. Conversion of minimally invasive distal pancreatectomy: predictors and outcomes. Ann Surg Oncol 2017; 24:3725–3731.
Goh BKP, Chan CY, Lee SY, et al. Factors associated with and consequences of open conversion after laparoscopic distal pancreatectomy: initial experience at a single institution. ANZ J Surg 2016; 8–10.
Halls MC, Cipriani F, Berardi G, et al. Conversion for unfavorable intraoperative events results in significantly worst outcomes during laparoscopic liver resection: lessons learned from a multicenter review of 2861 cases. Ann Surg 2018; 268:1051–1057.
Etter K, Davis B, Roy S, et al. Economic impact of laparoscopic conversion to open in left colon resections. JSLS J Soc Laparoendosc Surg 2017; 21:1–16.
Yang C, Wexner SD, Safar B, et al. Conversion in laparoscopic surgery: does intraoperative complication influence outcome? Surg Endosc 2009; 23:2454–2458.
Allaix ME, Furnée EJB, Mistrangelo M, et al. Conversion of laparoscopic colorectal resection for cancer: what is the impact on short-term outcomes and survival? World J Gastroenterol 2016; 22:8304.
Casadei R, Ricci C, Pacilio CA, et al. Laparoscopic distal pancreatectomy: which factors are related to open conversion? Lessons learned from 68 consecutive procedures in a high-volume pancreatic center. Surg Endosc Other Interv Tech 2018; 0:1–7.
Raoof M, Ituarte PHG, Woo Y, et al. Propensity score-matched comparison of oncological outcomes between laparoscopic and open distal pancreatic resection. Br J Surg 2018; 105:578–586.
Van Hilst J, de Rooij T, Klompmaker S, et al. Minimally invasive versus open distal pancreatectomy for ductal adenocarcinoma (DIPLOMA). Ann Surg 2019; 269:10–17.
Elm E, Von, Altman DG, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370:1453–1457.
Montagnini AL, Røsok BI, Asbun HJ, et al. Standardizing terminology for minimally invasive pancreatic resection. HPB 2017; 19:182–189.
Campbell F, Cairns A, Duthie F, et al. Dataset for the histopathological reporting of carcinomas of the pancreas, ampulla of Vater and common bile duct from the Royal College of Pathologists. Available at: https://www.rcpath.org/uploads/assets/34910231-c106-4629-a2de9e9ae6f87ac1/g091-pancreasdataset-mar17.pdf . 2017. Accessed October 3, 2018.
Isaji S, Mizuno S, Windsor JA, et al. International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017. Pancreatology 2018; 18:2–11.
Clavien PA, Barkun J, De Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 2009; 250:187–196.
Bassi C, Marchegiani G, Dervenis C, et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After. Surgery 2017; 161:584–591.
Jin T, Altaf K, Xiong JJ, et al. A systematic review and meta-analysis of studies comparing laparoscopic and open distal pancreatectomy. HPB 2012; 14:711–724.
De Rooij T, Cipriani F, Rawashdeh M, et al. Single-surgeon learning curve in 111 laparoscopic distal pancreatectomies: does operative time tell the whole story? J Am Coll Surg 2017; 224:826–832. e1.
Hua Y, Javed AA, Burkhart RA, et al. Preoperative risk factors for conversion and learning curve of minimally invasive distal pancreatectomy. Surgery 2017; 162:1040–1047.
Liu R, Liu Q, Zhao Z-M, et al. Robotic versus laparoscopic distal pancreatectomy: a propensity score-matched study. J Surg Oncol 2017; 461–469.
Abu Hilal M, Richardson JRC, de Rooij T, et al. Laparoscopic radical ‘no-touch’ left pancreatosplenectomy for pancreatic ductal adenocarcinoma: technique and results. Surg Endosc 2016; 30:3830–3838.
Plotkin A, Ceppa EP, Zarzaur BL, et al. Reduced morbidity with minimally invasive distal pancreatectomy for pancreatic adenocarcinoma. HPB 2017; 19:279–285.
Adam MA, Choudhury K, Goffredo P, et al. Minimally invasive distal pancreatectomy for cancer: short-term oncologic outcomes in 1733 patients. World J Surg 2015; 39:2564–2572.
Nakamura M, Wakabayashi G, Miyasaka Y, et al. Multicenter comparative study of laparoscopic and open distal pancreatectomy using propensity score-matching. J Hepatobiliary Pancreat Sci 2015; 22:731–736.
Stiles ZE, Dickson PV, Deneve JL, et al. The impact of unplanned conversion to an open procedure during minimally invasive pancreatectomy. J Surg Res 2018; 227:168–177.
Van Hilst J, de Rooij T, Abu Hilal M, et al. Worldwide survey on opinions and use of minimally invasive pancreatic resection. HPB 2017; 19:190–204.
Marinelli T, Filippone A, Tavano F, et al. A tumour score with multidetector spiral CT for venous infiltration in pancreatic cancer: Influence on borderline resectable. Radiol Medica 2014; 119:334–342.
Raman S, Reddy S, Weiss M, et al. Impact of the time interval between MDCT imaging and surgery on the accuracy of identifying metastatic disease in patients with pancreatic cancer. Am J Roengenol 2015; 204:W37–W42.
Beane JD, Pitt HA, Dolejs SC, et al. Assessing the impact of conversion on outcomes of minimally invasive distal pancreatectomy and pancreatoduodenectomy. HPB 2018; 20:356–363.
Lee SY, Allen PJ, Sadot E, et al. Distal pancreatectomy: a single institution's experience in open, laparoscopic, and robotic approaches. J Am Coll Surg 2015; 220:18–27.
Giglio MC, Celentano V, Tarquini R, et al. Conversion during laparoscopic colorectal resections: a complication or a drawback? A systematic review and meta-analysis of short-term outcomes. Int J Colorectal Dis 2015; 30:1445–1455.
Lee S, Kang C, Hwang H, et al. Minimally invasive RAMPS in well-selected left-sided pancreatic cancer within Yonsei criteria: long-term (>median 3 years) oncologic outcomes. Surg Endosc 2014; 28:2848–2855.
Ohtsuka T, Ban D, Nakamura Y, et al. Difficulty scoring system in laparoscopic distal pancreatectomy. J Hepatobiliary Pancreat Sci 2018; 25:489–497.
Lof S, Moekotte AL, Al-Sarireh B, et al. Multicentre observational cohort study of implementation and outcomes of laparoscopic distal pancreatectomy. Br J Surg 2019; 106:1657–1665.
Abu Hilal M, Jain G, Kasasbeh F, et al. Laparoscopic distal pancreatectomy: critical analysis of preliminary experience from a tertiary referral centre. Surg Endosc 2009; 23:2743–2747.

Auteurs

Sanne Lof (S)

Department of Surgery, Southampton University Hospital NHS Foundation Trust, Southampton, United Kingdom.
Department of Surgery, Poliambulanza Foundation Hospital, Brescia, Italy.

Maarten Korrel (M)

Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, The Netherlands.

Jony van Hilst (J)

Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, The Netherlands.

Alma L Moekotte (AL)

Department of Surgery, Southampton University Hospital NHS Foundation Trust, Southampton, United Kingdom.

Claudio Bassi (C)

Department of Surgery, Pancreas Institute, Verona University Hospital, Verona, Italy.

Giovanni Butturini (G)

Department of Surgery, Pederzoli Hospital, Peschiera, Italy.

Ugo Boggi (U)

Department of Surgery, Universitá di Pisa, Pisa, Italy.

Safi Dokmak (S)

Department of Surgery, Hospital of Beaujon, Clichy, France.

Bjørn Edwin (B)

The Intervention Centre, Department of HPB Surgery, Oslo University Hospital and Institute for Clinical Medicine, Oslo, Norway.

Massimo Falconi (M)

Pancreatic Department of Surgery, San Raffaele Hospital, Università "Vita e Salute", Cologno Monzese, Italy.

David Fuks (D)

Département de Chirurgie Digestive, Oncologique et Métabolique, Institut Mutualiste Montsouris, Paris, France.

Matteo de Pastena (M)

Department of Surgery, Pancreas Institute, Verona University Hospital, Verona, Italy.

Alessandro Zerbi (A)

Department of Surgery, Humanitas University Hospital, Milan, Italy.

Marc G Besselink (MG)

Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, The Netherlands.

Mohammed Abu Hilal (M)

Department of Surgery, Southampton University Hospital NHS Foundation Trust, Southampton, United Kingdom.
Department of Surgery, Poliambulanza Foundation Hospital, Brescia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH